State of play on the candidate list. of Substances of Very High Concern

Similar documents
REACH/CLP Update. Roseleen Murphy IMFI 12 th May 2011

9/10/2013. Contributions of ECHA to the achievement of the REACH goals. Content of Discussion

April 21 st, 2016 Webinar. registrations What is next for the industry?

ECHA and the implementation of REACH,CLP and other tasks

Update from ECHA. REACH Implementation Workshop X. 13 December Laurence Hoffstadt ECHA Substance Identification & Data Sharing

Final Minutes. Minutes of the 12th Meeting of the Member State Committee (MSC-12) 9-10 June 2010

Strategies for REACH Compliance. Chicago 23 March 2012

Implementation of REACH & CLP: common challenges of national authorities and ECHA

European Union Registration, Evaluation, and Authorization of Chemicals (REACH) Potential Impacts to DoD

Hazard Communication. Hazard Communication

CLP the implementation of GHS in the EU Facts and practical advice

Procedure for handling applications for authorisation and review reports under REACH

REACH Pre-registration Questions and Answers

1. Address by Dr. Chris SAID, Parliamentary Secretary for Consumers, Fair Competition and Public Dialogue

Guidance on Scientific Research and Development (SR&D) and Product and Process Orientated Research and Development (PPORD)

Newsletter September 2017

REACH Evaluation. Graham Lloyd Regulatory/Technical. REACH in Practice Conference 1 June, Steptoe & Johnson LLP & Regulatory Compliance Ltd

Intertek Health, Environmental & Regulatory Services

Guidance on the Biocidal Products Regulation

Guidance on the Biocidal Products Regulation

Multi-Annual Work Programme

CLP Regulation Recent implementation and issues. Workshop "Product Stewardship and PROCESS SAFETY 30/11/2017 Dr. Blanca Serrano

Final Draft Agenda Sixteenth meeting of the Forum for Exchange of Information on Enforcement (Forum-16) October 2013

Second REACH registration deadline a success. 3 Nearly more substances registered by industry. 10 Setting scientific. 14 Promoting substitution

FORUM FOR EXCHANGE OF INFORMATION ON ENFORCEMENT. Disclaimer:

Guidance on the preparation of dossiers for harmonised classification and labelling (CLH) under Regulation (EC) No.

ASSESSMENT OF THE CONSOLIDATED ANNUAL ACTIVITY REPORT OF THE AUTHORISING OFFICER FOR THE YEAR 2014

REACH and CLP an industrial perspective on registrations and notifications

REACH Forum, Compliance Control of REACH and CLP Regulations

SDS and what is new under REACH and EU GHS? PRISM2 Workshop Promoting Resposibility in SME s 08 April Slovakia. L. Heezen

VLARIP Netwerkevent. 24 januari 2013

Future road of REACH. Checking out the map. Fulvia Raffaelli Unit G.1 : Chemicals, REACH. European Commission Enterprise and Industry

Biocidal product regulation the changes to come

REACH-IT Industry User Manual

Novità in materia di CLP : impatto sui biocidi. Maristella Rubbiani CSC/ISS

Practical guide 7: How to notify substances in the Classification and Labelling Inventory

Questions and answers about Recycling Processes

REPORTING OF REACH IMPLEMENTATION

Introduction UN GHS. CLP outline. Requirement for SDS. Measures needed GHS CLP SDS. Transition from DSD/DPD to CLP DSD/DPD CLP

Bilateral screening: Chapter 27 PRESENTATION OF THE REPUBLIC OF SERBIA Classification, labelling and packaging of substances and mixtures - CLP

The Classification and Labelling Inventory. Cefic s viewpoint

REPUBLIC OF SERBIA Bilateral screening: Chapter 1 Free Movement of Goods. C L P Classification, Labeling and Packaging of substances and mixtures

Agenda. Workflows and Software Tools for the Process of Registration, Evaluation, Authorisation and Restriction of European Chemicals

Background to CLP. Presentation Overview. Why Introduce GHS? Basic CLP requirements 8/30/2011

LISAM SYSTEMS REACH Compliant SDSs: What s Changed and What s Coming

Harmonisation of Information for Poison Centres

EU harmonization of the information for emergency health response (Art. 45 Regulation 1272/2008 )

The implementation of the Clinical Trial Regulation (CTR, n 536/2014) in Belgium. and impact on the ethical review process

CHEMICALS (Classification, Labelling, Packaging of substances and mixtures -CLP) Screening Meeting EU Serbia June 2013

Europe Direct is a service to help you find answers to your questions about the European Union.

Commission Guidelines for the implementation of the Clinical Trials Regulation NTA Ethics Oslo

Confirmation Letter of REACH Registration

Update of the Work plan on international activities 2012

Classification & Labelling and ECHA Support to Industry

Global REACH legal services

Health and Safety Authority. Function and Scope of REACH and CLP Helpdesks

From pre-registration to joint submission Hendrik Abma Director General European Association of Chemical Distributors (FECC)

European IVD Regulations and Risk Based Classification. An Overview for Global Quality Professionals

Changes to Chemical Labels and SDS - Speaker s notes

CHEMICAL WATCH GLOBAL ENFORCEMENT SUMMIT 2015

Adopted by Pharmacovigilance Risk Assessment Committee 20 February Adopted by Pharmacovigilance Inspectors Working Group 21 March 2014

Guideline for Complying with Regulations of Substances Control (CRSC)

A World Class Leader in Training and Development. Safety Training. Safety Training. Global Learning Services

BETTER REGULATION OF MEDICINES INITIATIVE (BROMI): FIFTH REPORT ON PROGRESS

Current and future standardization issues in the e Health domain: Achieving interoperability. Executive Summary

1. Applications must contain the following information (Article 33 of Regulation)

ITMA 2015 Textile Colourant & Chemical Leaders Forum. Updates on REACH Regulation. Dr Maurizio Colombo, REACH and CPL Coordinator, Federchimica

essenscia SME projects to improve REACH & CLP implementation: VLARIP & WALRIP

Board Secretary. Position Description

- Proposal for a Regulation on HTA- Ioana Siska, MD, PhD DG SANTE - Health Systems and Products Medical Products: safety, quality, innovation

EU Poison Centres Webinar. 27 May 2014, 9:00am BST

1 The EU Harmonised technical ectd guidance version 4.0

CMDv/BPG/002. BEST PRACTICE GUIDE for Veterinary Decentralised Procedure (DCP)

European CE Marking of Medical Devices. October 2017

Regulation 347/2013 as adopted and adapted in the Energy Community

Annex 2 to the HMA esubmission Roadmap: Implementation of mandatory use of ectd format for regulatory submissions

GUIDELINES ON MEDICAL DEVICES CLINICAL INVESTIGATIONS: SERIOUS ADVERSE EVENT REPORTING

EUCERD RECOMMENDATIONS QUALITY CRITERIA FOR CENTRES OF EXPERTISE FOR RARE DISEASES IN MEMBER STATES

Australian/New Zealand Standard

Contact Details: Topic 5 ICT platform for Learning and Inclusion. Telephone number

Delivery time frame for the EU portal and EU database

To detail the context, purpose and expectations related to Health, Safety and Wellbeing processes relating to the RMIT Community.

Regulatory fitness check of chemicals legislation

REGISTRATION OF MEDICINES IN THE EURASIAN ECONOMIC UNION

III. The provider of support is the Technology Agency of the Czech Republic (hereafter just TA CR ) seated in Prague 6, Evropska 2589/33b.

Call title: Science in Society 2013

GUIDELINES ON PARTICIPATION IN EU EXTERNAL AID PROGRAMMES

Guideline on good pharmacovigilance practices (GVP)

New European Union Clinical Trial Regulations

Therapeutic Use Exemption (TUE) Checklist and Application

Australia s National Guidelines and Procedures for Approving Participation in Joint Implementation Projects

Recommendation on duplicate applications in mutual recognition and decentralised procedures

European Maritime Safety Agency. Training on Maritime Security October Obligations for. Maritime Administrations

TECHNICAL AND COMPLIANCE COMMITTEE

Report on status of on-going Article 45 & 46 work-sharing procedure. Shirley NORTON MHRA (UK) Alban DHANANI AFSSAPS (FR)

Guideline on good pharmacovigilance practices (GVP)

EC payments, reports and audits Horizon 2020 Legal and finance training 2nd 3rd November 2015

Erasmus+ EU-funded scholarships to study in Europe. Erasmus+

Green Industry Innovation Programme Poland. Call for Project Proposals

COMMISSION DELEGATED DIRECTIVE../ /EU. of

Transcription:

State of play on the candidate list of Substances of Very High Concern Finn Pedersen, ECHA ECHA s First Stakeholders Day 10 October 2008, Helsinki

Contents What is the candidate list? How will it be developed? Where are we now? Next steps

The candidate list Establishment of the candidate list is part of the authorisation procedure Consists of substances that have been identified as meeting the criteria for being Substances of Very High Concern (Art. 57) These substances are candidates for eventual inclusion in Annex XIV (the authorisation list ) following a prioritisation process The candidate list has not yet been established!

Authorisation procedure Step 1: Identification of substances for the candidate list Prioritisation of substances Inclusion of substances on authorisation list Step 2: Application for authorisation Granting of authorisation Review of authorisation

Identification of SVHCs, inclusion in the Candidate list and inclusion of substances in the Authorisation list (Annex XIV) Member State or Agency submits an Annex XV dossier Comments - Authorities - Interested parties MSC Agreement / COM decision Candidate list Agency recommends priority substances COM decision Authorisation list

Identification of SVHC for candidate list MS (or ECHA on behalf of COM) includes substance in Registry of Intentions Submission of Annex XV dossiers (focussing on hazardous properties) Accordance check by ECHA Publication of Annex XV reports for comments Development of Support Document (incl. responses to comments) by MS and ECHA Agreement on identification by ECHA s Member State Committee (if comments are received) Inclusion in candidate list Approximately 4.5-5 months

Where are we now? MSs have submitted proposals for 16 substances by early June, 2008 Consultation period: 30 June 14 August, 2008 Comments have been received on all substances 7 MSCAs National and international NGOs, industry associations, companies, national authorities, individuals from EU, US and Japan

Comments received In general the comments received by MSCAs support the proposal of identifying the substance as a SVHC Except for one substance where one MSCA does not support the proposal Many comments on use and exposure (not relevant for the identification discussion, but will considered for prioritisation for inclusion in the authorisation list ) General questions raised by some MSCAs regarding scope of some of the entries and necessity to place the substance on the candidate list have been referred to the REACH CA meeting

MSC agreements Member State Committee meeting 7-8 October 2008: Confirmed 1 substance as SVHC without discussion, as no comments on identification had been received Confirmed 10 substances as SVHC without discussion after written consultation Reached agreement on 4 substances as SVHC after discussion Reached agreement on 1 substance (cyclododecane) that insufficient information is available to judge the fulfilment of the criteria

Substances identified as CMR 4,4 -Methylene dianiline (C) Bis(2-ethylhexyl)phthalate (R) Dibutylphthalate (R) Benzylbutylphthalate (R) Cobalt dichloride (C) Triethyl arsenate (C) Lead hydrogen arsenate (CR) Diarsenic trioxide (C) Diarsenic pentaoxide (C) Sodium dichromate (CMR)

Substances identified as PBTs, vpvbs Alkanes, C10-13, chloro- (SCCP) (PBT & vpvb) Anthracene (PBT) Bis(tributyltin)oxide (TBTO) (PBT) Hexabromocyclododecane (HBCDD) (PBT) Musk xylene (vpvb)

What s next? ECHA adds the SVHC substances to the candidate list by end of October, 2008 Immediate obligations following inclusion in the candidate list Any supplier of an article containing the substance >0.1% (w/w) shall provide information to professional users on safe use incl. name of substance (Art. 33(1)) Any supplier of an article containing the substance >0.1% (w/w) shall, within 45 days of request, provide sufficient information to consumers on safe use incl. name of substance (Art. 33(2))

What s next Further obligations: Producers and importers of articles containing substances on the candidate list in a concentration >0.1% and in total >1 t/y must notify the substance to ECHA (Art. 7(2), applies from 1 June 2011) Suppliers shall provide an SDS for substances or preparations containing substances on the candidate list (Art. 31(1)(c), essentially only substances identified as being of an equivalent level of concern, i.e. Art. 57(f))

Next steps Priority setting and preparation of the Annex XIV proposals in October-November MSC consultation in December-January Public consultation from January-April Review of comments in May MSC consultation end of May Approximately 7 months Recommendation to COM before June

Annex XIV entries Authorisation list entries contain (cf. Art. 58(1)): Identity of the substance Intrinsic properties of the substance referred to in Art. 57 (CMR, PBT, vpvb, equivalent concern) Transitional arrangements The sunset date Application date (at least 18 months before the sunset date) Review periods for certain uses, if appropriate Uses or categories of uses exempted from the authorisation requirements, if any, and conditions for such exemptions, if any

Granting (or refusing) the authorisation Applicant applies for authorisation for a substance on Annex XIV Interested parties - Information on alternatives Agency C ttees draft opinions Applicant s comments Agency C ttees opinions Review of authorisation Applicant s review report Authorisation granted / not granted COM decision

Timelines for first authorisations First Candidate list Oct 2008 First Annex XIV proposals June 2009 Annex XIV published [Autumn 2009] First application date [Spring 2011] COM draft proposal [Autumn 2012] First approvals [Early 2013]

Conclusions Authorisation is a complex and heavy process We are still at the start, there are many points to explore and hurdles to overcome Guidance has been developed but this new process will need learning-by-doing The candidate list is a living list ECHA s mission is to get the whole REACH machinery to work efficiently and effectively Authorities should carefully consider the best risk management option

Thank you for your attention